Emergent Biosolutions INC.

biopharmaceutical company

Based in DC

🤖

AI Overview

With $650K in lobbying spend across 13 quarterly filings, Emergent Biosolutions INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2021.

$650K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$200K
2019	$200K
2020	$200K
2021	$50K

Issues Lobbied

Budget/Appropriations Defense Health Issues Homeland Security

Lobbying Firms

Milne, Wiener & Shofe Global Strategies (FKA M & W Government Affairs, LLC)

Lobbyists

John Milne Jeffrey Wiener

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Defense, Health Issues, Homeland Security

•FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
•FY 2019 Appropriations - provisions related to development,

•H.R.2810 - National Defense Authorization Act for Fiscal Year 2018, provisions related to biological and chemical defense

•Issues related to homeland security, emergency preparedness and response, the reauthorization of the Pandemic and All-Hazards Preparedness Act, and the strategic national vaccine stockpile.